In one paragraphArticle in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
7 authors at 2 institutions in 1 country.
Monserrat Olea-FloresDepartment Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0003-1813-9062 Tapan SharmaDepartment Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0003-2495-2236 Odette Verdejo-TorresDepartment of Molecular Biology and Biochemistry, Wesleyan University, Middletown, CT, USA.ORCID 0009-0006-6955-5428 Imaru DiBartolomeoDepartment of Molecular Biology and Biochemistry, Wesleyan University, Middletown, CT, USA.ORCID 0009-0004-4877-6163 Paul R ThompsonDepartment Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0002-1621-3372 Teresita Padilla-BenavidesDepartment of Molecular Biology and Biochemistry, Wesleyan University, Middletown, CT, USA.ORCID 0000-0002-4624-0822 Anthony N ImbalzanoDepartment Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0003-0744-3413 Wesleyan University · USUniversity of Massachusetts Chan Medical School · US
Funding
Chemical probes to decipher PAD biologyR35GM118112 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Paul R Thompson · 2016 to 2026
$9.5MMolecular and Cellular Dynamics in Mammalian Signal TransductionR35GM136392 · NIGMS · UNIVERSITY OF COLORADO · PI NATALIE G. AHN · 2020 to 2026
$4.2MRegulation of gene expression by chromatin remodeling enzymes - Administrative SupplementR35GM136393 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI IMBALZANO, ANTHONY N · 2020 to 2024
$2.1MMechanisms of Cu-binding factors to promote myogenic gene expressionR01AR077578 · NIAMS · WESLEYAN UNIVERSITY · PI Teresita Del Nino Jesus Padilla-Benavides · 2021 to 2026
$2.1MNIAMS NIH HHS R01 AR077578NIGMS NIH HHS R35 GM118112NIGMS NIH HHS R35 GM136392NIGMS NIH HHS R35 GM136393
6 · The paper itselfAbstract
Pyruvate kinase is a glycolytic enzyme that converts phosphoenolpyruvate and ADP into pyruvate and ATP. There are two genes that encode pyruvate kinase in vertebrates;
Indexed as
chromatin remodeling enzymesgene regulationH3 phosphorylationmyoblast differentiationPyruvate kinaseSWI/SNF
Identifiers
PMID38645038
PMCPMC11030359
OpenAlexW4394758684
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390